Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy

REFERENCES

• Baguly E.E., Rommele C., Gruneco J., Weheli W. Papulacandin B: an inhibitor of glucan synthesis in yeast spheroplast. European Journal of Biochemistry 1979; 97: 345–351
   PubMedGoogle Scholar
• Benz F., Knusel F., Nuesch J. Echinocandin B, ein neuartiges polypetid antibiotikum aus Aspergillus nidulans var. echinulatus. Isolierung und bausteine. Helvetica Chimica Acta 1974; 57: 2459–2477
   PubMed Web of Science ®Google Scholar
• Bonaly R., Dari L., Kubiak C., Lejeune J., Poulain D. Altérations des parois de Candida albicans cultivées en présence de doses subléthales de nystatine. Annales de l'Institut Pasteur Microbiologie 1985; 136B: 181–193
   PubMedGoogle Scholar
• Borgers M. Ultrastructural correlates of antimycotic treatment. Current Topics in Medical Mycology, M.R. McGinnis. Springer-Verlag, New York 1988; Vol. 2: 1–39, In
   Google Scholar
• Bozzola J.J., Mehta R.J., Nisbet L.J., Valenta J.R. The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicans. Canadian Journal of Microbiology 1984; 30: 857–863
   PubMed Web of Science ®Google Scholar
• Cabib E., Roberts R., Bowers B. Synthesis of the yeast cell wall and its regulation. Annual Review of Biochemistry 1982; 51: 763–793
   PubMed Web of Science ®Google Scholar
• Cassone A. Cell wall of Candida albicans: its function and its impact on the host. Current Topics in Medical Mycology, M.R. McGinnis, M. Borgers. Springer-Verlag, New York 1989; Vol. 3: 248–314, In
   Google Scholar
• Cassone A., Mason R., Kerridge D. Lysis of growing yeast form cells of Candida albicans by echinocandin. A cytological study. Sabouraudia 1981; 19: 97–110
   PubMedGoogle Scholar
• Cassone A., Simonetti N., Strippoli V. Ultrastructural changes in the wall during germtube formation from blastospores of Candida albicans. Journal of General Microbiology 1973; 77: 417–420
   PubMedGoogle Scholar
• Debono M., Abbott B.J., Turner J.R., Howard L.C., Gordee R.S., Hunt A.S., Barnhart M., Molloy M., Willard K.E., Fukuda D., Butler T.F., Zeckner D.J. Synthesis and evaluation of LY 121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B. Annales of the New York Academy of Sciences 1988; 544: 152–167
   PubMedGoogle Scholar
• Fungal Antigens, E. Drouhet, G. Cole, L. de Repentigny, J.P. Latge, B. Dupont. Plenum Press, New York 1988
   Google Scholar
• Drouhet E., Dupont B., Improvisi L. Antifungal activity of a new semi-biosynthetic antifungal agent (LY 121019). Sensitivity of Candida albicans strains from AIDS patients and resistant strains to various antifungal agents. 28th International Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, 1988; 379–379, Abstract No. 511
   Google Scholar
• Drouhet E., Dupont B., Improvisi L., Lesourd M., Prevost M.C. La cilofungine (LY 121019), nouvel antifongique lipopolypeptidique agissant sur la paroi fongique. Activité in vitro sur les levures. Bulletin de la Société Française de Mycologie Médicale 1989; 18: 31–46
   Google Scholar
• Drouhet E., Dupont B., Improvisi L., Viviani M.A., Tortorano A.M. Disc agar diffusion and microplate automatized technics for in vitro evaluation of antifungal agents on yeasts and sporulated pathogenic fungi. In vitro and in vivo evaluation of antifungal agents, K. Iwata, H. Vanden Bossche. Elsevier Science Publ. B.V., Amsterdam 1986; 31–49, In
   Google Scholar
• Fleet G.M. Composition and structure of yeast cell walls. Current Topics in Medical Mycology, M.R. McGinnis. Springer-Verlag, New York 1985; Vol. 1: 24–56, In
   Google Scholar
• Garzon S., Marquis G., Kurstak E., Montplaisir S., Benhamou N. Antigenic structure of Candida albicans. Electron microscopic localization of polysaccharide and immunodeterminants in the cell wall. Immunology of Fungal Diseases, E. Kurstak. Marcel Dekker, New York 1989; 3–36, In
   Google Scholar
• Gopal P.K., Shepherd M.G., Sullivan P.A. Analysis of wall glucans from yeast, hyphal and germ tube forming cells of Candida albicans. Journal of General Microbiology 1984; 130: 3295–3300
   PubMedGoogle Scholar
• Gordee R.S., Zeckner D.J., Alborn W.E., Jr. Action of LY 121019 on Candida albicans cell wall biosynthesis. 27th International Conference on Antimicrobial Agents and Chemotherapy, New York, 1987; 267–267, Abstract 977
   Google Scholar
• Gordee R.S., Zeckner D.J., Ellis L.F., Thakkar A.L., Howard L.C. In vitro and in vivo anti-Candida activity and toxicology of LY 121019. Journal of Antibiotics 1984; 37: 1054–1065
   PubMed Web of Science ®Google Scholar
• Gordee R.S., Zeckner D.J., Howard L.C., Alborn W.E., Jr, Debono M. Anti-Candida activity and toxicology of LY 121019, a novel semisynthetic polypeptide antifungal antibiotic. Annales of the New York Academy of Sciences 1988; 544: 294–309
   PubMedGoogle Scholar
• Hobbs M., Perfect J., Durack D. Evaluation of in vitro antifungal activity of LY 121019. European Journal of Clinical Microbiology and Infectious Diseases 1988; 7: 77–80
   PubMed Web of Science ®Google Scholar
• Iwata K.Y., Yamamoto H., Yamaguchi H., Hiratani T. In vitro studies of aculeacin A, a new antifungal antibiotic. Journal of Antibiotics 1982; 35: 203–209
   PubMed Web of Science ®Google Scholar
• Mehta R.J., Nash C.H., Grappel S.F., Actor P. Aculeacin A resistant mutants of Candida albicans. JOurnal of Antibotics 1982; 35: 707–711
   PubMed Web of Science ®Google Scholar
• Melchinger W., Muller J. Studies on the in vitro sensitivity of yeast strains isolated from clinical specimens to LY 121019, a new antifungal agent. Mykosen 1987; 30: 605–608
   PubMedGoogle Scholar
• Mizoguchi J., Saito T., Mizuno K., Hayano K. On the mode of action of a new antifungal antibiotic, aculeacin A: inhibition of cell wall synthesis in Saccharomyces cerevisiae. Journal of Antibiotics 1977; 30: 308–313
   PubMed Web of Science ®Google Scholar
• Mizuno K., Yagi A., Satoi S., Takada M., Hayashi M., Asano K., Matsuda T. Studies on aculeacin I. Isolation and characterization of aculeacin A. Journal of Antibiotics 1977; 30: 297–302
   PubMed Web of Science ®Google Scholar
• Muller J. Activité in vivo de la cilofungine (LY 121019), dérivé d'échinocandine. Bulletin de la Société Française de Mycologie Médicale 1989; 18: 47–50
   Google Scholar
• Muller J., Scheidecker I. Immunoelectronmicroscopic studies on the influence of an echinocandin B analog on the cell wall antigenicity of Candida albicans. Poster. 10th Congress International Society of Human and Animal Mycology. ISHAM, Barcelona 1988
   Google Scholar
• Murgui A., Elorza M.V., Sentandreu R. Effect of papulacandin B and calcofluor white on the incorporation of mannoproteins in the wall of Candida albicans blastospores. Biochimica et Biophysica Acta 1985; 841: 215–222
   PubMed Web of Science ®Google Scholar
• Murgui A., Elorza M.V., Sentandreu R. Tunicamycin and papulacandin B inhibit incorporation of specific mannoproteins into the wall of Candida albicans regenerating protoplasts. Biochimica et Biophysica Acta 1986; 885: 550–558
   Web of Science ®Google Scholar
• Odds F.C. Candida and Candidosis. A Review and Bibliography2nd edn. Ballière-Tindall, London 1988
   Google Scholar
• Orlean P.A.B. 1,3-β-D-glucan synthetase from budding and filamentous cultures of the dimorphic fungus Candida albicans. European Journal of Biochemistry 1982; 127: 397–403
   PubMedGoogle Scholar
• Perez P., Varona R., Garcia-Acha I. Effect of papulacandin B and aculeacin A on β-(1,3) glucan-synthase from Geotrichum lactis. FEBS Letters 1981; 129: 249–252
   Web of Science ®Google Scholar
• Ruiz-Herrera J., Sentandreu R. Fungal cell wall synthesis and assembly. Current Topics in Medical Mycology, M.R. McGinnis, M. Borgers. Springer-Verlag, New York 1989; Vol. 3: 168–217, In
   Google Scholar
• Sawitowska-Schroder E.T., Kerridge D., Perry H. Echinocandin inhibition of 1,3-β-D-glucan synthase from Candida albicans. FEBS Letters 1984; 173: 134–138
   PubMed Web of Science ®Google Scholar
• Scherwitz C., Martin R., Ueberberg H. Ultrastructural investigations of the formation of Candida albicans germ tubes and septa. Sabouraudia 1978; 16: 115–124
   PubMedGoogle Scholar
• Shematek E.M., Broatz J.A., Cabib E. Biosynthesis of the yeast cell wall. I. Preparation and properties of a β(1,3) glucan synthetase. Journal of Biological Chemistry 1980; 255: 888–894
   PubMed Web of Science ®Google Scholar
• Shematek E.M., Cabib E. Biosynthesis of the yeast cell wall. II. Regulation of β(1,3) glucan synthetase by ATP and GTP. Journal of Biological Chemistry 1980; 255: 895–902
   PubMed Web of Science ®Google Scholar
• Shepherd M.G. Cell envelope of Candida albicans. CRC Critical Reviews in Microbiology 1987; 15: 7–25
   Web of Science ®Google Scholar
• Shepherd M.G. Morphogenetic transformation of fungi. Current Topics in Medical Mycology, M.R. McGinnis. Springer-Verlag, New York 1988; Vol. 2: 278–304, In
   Google Scholar
• Strippoli V., D'Auria E.D., Simonetti N. A study of the antifungal activity of LY 121019, a new echnocandin derivative. Chemioterapia 1988; 7: 33–37
   PubMedGoogle Scholar
• Sullivan P.A., Chiew Y.Y., Molloy C., Templeton M.D., Shepherd M.G. An analysis of the metabolism and cell wall composition of Candida albicans during germ-tube formation. Canadian Journal of Microbiology 1983; 29: 1514–1525
   PubMed Web of Science ®Google Scholar
• Surarit R., Shepherd M.G. The effects of azole and polyene antifungals on the plasma membrane enzymes of Candida albicans. Journal of Medical and Veterinary Mycology 1987; 25: 403–413
   PubMedGoogle Scholar
• Taft C.S., Stark T., Selitrennikoff C.P. Cilofungin (LY 121019) inhibits Candida albicans (1,3)-β-glucan synthase activity. Antimicrobial Agents and Chemotherapy 1988; 32: 1901–1903
   PubMed Web of Science ®Google Scholar
• Traxles P., Gruner J., Auden J.A.L. Papulacandin, a new family with antifungal activity. I. Fermentation, isolation, chemical and biological characterization of papulacandin A, B, C, D and E. Journal of Antibiotics 1977; 30: 289–296
   PubMed Web of Science ®Google Scholar
• Vanden Bossche H. Importance and role of sterols in fungal membranes. Biochemistry of Cell Walls and Membranes in Fungi, P.J. Kuhn, A.P.J. Trinci, M.J. Jung, M.W. Goosey, L.G. Copping. Springer-Verlag, Berlin 1990; 135–157, In
   Google Scholar
• Vanden Bossche H., Willemsens G., Marichal P. Anti-Candida drugs. The biochemical basis for their activity. CRC Critical Reviews in Microbiology 1987; 15: 57–72
   Google Scholar
• Yamaguchi H., Hiratani T., Baba M., Osumi M. Effect of aculeacin A, a wall-active antibiotic, on synthesis of the yeast cell wall. Microbiology and Immunology 1985; 29: 609–623
   PubMed Web of Science ®Google Scholar
• Yamaguchi H., Hiratani T., Iwata K., Yamamoto Y. Studies on the mechanism of antifungal action of aculeacin A. Journal of Antibiotics 1982; 35: 210–219
   PubMed Web of Science ®Google Scholar